Pfizer Insiders Lining Up to Sell After Vaccine Announcement

The insider selling activity in Pfizer isn’t exactly a strong indication to short the stock. However, it does give the impression that the price is relatively overvalued near $42.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.